1. "2016"
Formats
  1. Journal Article (2949)
  2. Meeting Abstract (1606)
  3. Book Section (155)
  4. Conference Paper (36)
  5. Book Whole (14)
Groups
  1. Department of Medicine (1963)
  2. GSK Faculty (1162)
  3. Solid Tumor Oncology Division (1064)
  4. Surgery (904)
  5. Survivorship Research (795)
  6. Center for Hematologic Malignancies (777)

More Groups

People
  1. Michael Berger (93)
  2. Jedd Wolchok (84)
  3. Robert Motzer (74)
  4. Sergio Giralt (73)
  5. Miguel-Angel Perales (69)
  6. Jose Baselga (67)

More People

Years
  1. 2016 (4760)
Publications
  1. Journal of Clinical Oncology (469)
  2. Blood (210)
  3. Modern Pathology (124)
  4. Laboratory Investigation (108)
  5. International Journal of Radiation Oncology, Biology, Physics (104)
  6. Annals of Oncology (94)

More Publications

Publishers
  1. Elsevier Inc. (519)
  2. American Society of Clinical Oncology (497)
  3. Springer (349)
  4. Nature Publishing Group (322)
  5. Oxford University Press (248)
  6. American Society of Hematology (213)

More Publishers

Results (4760)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2, open-label, multicenter study of durvalumab (MEDI4736) ± tremelimumab in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC): ALPS
    Meeting Abstract

    O'Reilly, E. M.; Oh, D. Y.; Lee, M. A.; Dhani, N.; Armstrong, J.; Belli, R.; Ferro, S.; Ben, Y.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • The EMPOWER study: Promoting breast cancer screening-A randomized controlled trial (RCT) in the Childhood Cancer Survivor Study (CCSS)
    Meeting Abstract

    Oeffinger, K. C.; Ford, J.; Moskowitz, C. S.; Chou, J. F.; Henderson, T. O.; Hudson, M. M.; Diller, L.; McDonald, A.; Ford, J.; Mubdi, N. Z.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Risk of arterial thromboembolism in patients with colorectal cancer
    Meeting Abstract

    Navi, B. B.; Reiner, A. S.; Kamel, H.; Okin, P. M.; Iadecola, C.; Elkind, M. S. V.; Panageas, K.; DeAngelis, L. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase I trial of a dual TOR kinase and DNA-PK inhibitor (CC-115) in advanced solid and hematologic cancers
    Meeting Abstract

    Munster, P. N.; Mahipal, A.; Nemunaitis, J. J.; Mita, M. M.; Paz-Ares, L. G.; Massard, C.; Mikkelsen, T.; Cruz, C.; Rathkopf, D. E.; Blumenschein, G. R.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • The RISC nomogram (RN) to predict overall survival (OS) of patients (pts) with metastatic urothelial carcinoma (mUC) receiving first-line platinum-based combination chemotherapy (CT)
    Meeting Abstract

    Necchi, A.; Sonpavde, G.; Lo Vullo, S.; Bamias, A.; Crabb, S. J.; Harshman, L. C.; Bellmunt, J.; De Giorgi, U.; Sternberg, C. N.; Ladoire, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • The effect of geography and the availability of second-line therapy on overall survival in a one-way crossover design study in renal cell carcinoma
    Meeting Abstract

    Needle, M. N.; Hutson, T. E.; Motzer, R. J.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Inherited mutations in DNA repair genes in men with metastatic castration-resistant prostate cancer
    Meeting Abstract

    Nelson, P.; Mateo, J.; Beltran, H.; De Sarkar, N.; Elemento, O.; Rubin, M. A.; Vinson, J. N.; Filipenko, J.; Robinson, D. R.; Chinnaiyan, A. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Clinical activity and safety of pegylated human IL-10 (AM0010) in combination with anti-PD1
    Meeting Abstract

    Naing, A.; Papadopoulos, K. P.; Infante, J. R.; Wong, D. J. L.; Autio, K. A.; Ott, P. A.; Falchook, G. S.; Patel, M. R.; Pant, S.; Patnaik, A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Clinical activity of anti -programmed death-1 (PD-1) agents in acral and mucosal melanoma
    Meeting Abstract

    Munhoz, R. R.; Shoushtari, A. N.; Kuk, D.; Ott, P. A.; Johnson, D. B.; Tsai, K. K.; Rapisuwon, S.; Eroglu, Z.; Sullivan, R. J.; Luke, J. J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Updated results: A phase InIa randomized trial of radium-223 + docetaxel versus docetaxel in patients with castration-resistant prostate cancer and bone metastases
    Meeting Abstract

    Morris, M. J.; Loriot, Y.; Sweeney, C.; Fizazi, K.; Ryan, C. J.; Shevrin, D. H.; Antonarakis, E. S.; Reeves, J.; Chandrawansa, K.; Kornacker, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save